Form 4: Twist Bioscience CFO Adam Laponis Sells Shares to Cover Tax Obligations

Adam Laponis, CFO of Twist Bioscience, sold 842 shares of common stock on July 9, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On July 9, 2024, Adam Laponis, the Chief Financial Officer of Twist Bioscience Corp, sold 842 shares of the company's common stock.
• The sale was executed at a price of $48.913 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Laponis directly owns 73,602 shares of Twist Bioscience Corp.
• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction to cover tax obligations. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.

Stakeholder Impact

• The sale of shares by the CFO could have a minor impact on shareholder sentiment, although it is a routine transaction.

Key Dates